american heart association glp-1 drugs can help you lose weight. They can't do this. A new statement, just published in JAMA, makes a point that doesn't get nearly enough attention in the Nutritional priorities to support GLP-1

These include dietary interventions, orlistat, lorcaserin, phentermine/topiramate, glucagon-like peptide-1 receptor agonists, dipeptidyl peptidase-4 inhibitors, pramlintide, dapagliflozin, the duodenaljejunal bypass liner, gastric pacemakers and gastric balloons

Later this year, we expect to launch

You'll learn about their mechanisms, common side effects, best administration practices, body mass index (BMI), and supportive lifestyle changes.

By 2030, the global prevalence of obesity is expected to reach one billion

Many individuals experience energy dips during GLP-1 therapy

While these agents are not recommended during pregnancy, their use in the preconception, periconception, and postpartum periods is increasing